pharma · HER2-positive · CARM
Carisma Therapeutics
Carisma Therapeutics is a pharma organization headquartered in Philadelphia, USA. It trades on NYSE under ticker CARM. Primary therapeutic focus areas include HER2-positive. NovaPharmaNews links 2 clinical program(s), 0
Philadelphia, USA HQ
2016 Founded
15 Employees
Public company Type
CARM · NYSE Ticker
Company details
- Status
- Public
- HQ
- Philadelphia, USA
- Founded
- 2016
- Employees
- 15
- Programs
- 2
- Drugs
- 1
- Patents
- 2
CT-0508
Phase 1 · mab · HER2-positive
CT-0508 for HER2-positive is a Phase 1 program (mab) at Carisma Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code 101
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Carisma Therapeutics
- Phase
- Phase 1
- Modality
- mab
- Indication
- HER2-positive
- Status
- active
- Trials
- 1